PRCT CTO sells 358 shares in tax sell-to-cover trade
PROCEPT BioRobotics EVP and CTO Barry L. Templin reported a small sale of 358 shares of Common Stock on June 8, 2026 at $28.479 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PROCEPT BioRobotics EVP and CTO Barry L. Templin reported a small sale of 358 shares of Common Stock on June 8, 2026 at $28.479 per share. According to the footnotes, this transaction was executed under the company’s sell-to-cover process to satisfy tax withholding obligations related to Restricted Stock Units that vested on June 5, 2026, indicating it was a routine tax-driven event rather than a discretionary sale. After this transaction, Templin directly holds 68,953 shares of PROCEPT BioRobotics common stock. The footnotes also note that his holdings include 860 shares acquired on May 14, 2026 through the company’s 2021 Employee Stock Purchase Plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 358 | $28.479 | $10K |
Footnotes (2)
- F1. The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on June 5, 2026.
- F2. Includes 860 shares acquired on May 14, 2026, under the Issuer's 2021 Employee Stock Purchase Plan.
Key Figures
Key Terms
sell-to-cover financial
Restricted Stock Units financial
Employee Stock Purchase Plan financial
open-market sale financial
AI-generated analysis. How Rhea-AI works. Not financial advice.